Infant heart drug under the microscope: new study aims to uncover how digoxin works

NCT ID NCT06613477

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times

Summary

This study looks at how the heart medication digoxin is processed by the bodies of infants with a rare heart condition called single ventricle heart disease. About 20 babies under 6 months old will participate, and researchers will collect blood samples during routine care to measure drug levels. The goal is to learn more about the drug's effects, not to change the baby's treatment plan.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFANT, PREMATURE, DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27701, United States

    Contact Email: •••••@•••••

  • Medical University of South Carolina

    NOT_YET_RECRUITING

    Charleston, South Carolina, 29425, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.